KristiMed
ActiveSummary
KristiMed has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €115k and a net result of €8k. Equity is growing by ~14.7% per year across the filed fiscal years. Its solvency ranks better than 25% of 1247 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
70
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability71▼-6
Solvency49▼-28
Growth52=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity ample (current ratio 1.83 against 2.66 in 2023; short-term debt: 8.6% and cash: 4% of total assets), but 75.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
24.1%
Return on assets
1.6%
Age of the figures
21 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 25% of 1247 sector peers (2024).
NBB · sector comparisonPosition among 1247 sector peers
Solvency
better than 25%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
not confirmed
2024
60 d late
2023
10 d late
2022
121 d late
2021
31 d late
2020
1 d early
2019
48 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€8k▼ 39.4%
2023 · €13k
2018: €28k
2019: €-21k
2020: €23k
2021: €35k
2022: €10k
2023: €13k
2018 → 2024
Working capital
€34k▼ 45.0%
2023 · €61k
2018: €42k
2019: €21k
2020: €42k
2021: €73k
2022: €52k
2023: €61k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€49k-€84k▲ 70.1%€94k▲ 12.0%€107k▲ 13.8%€115k▲ 7.3%
Operating result€33k-€51k▲ 53.3%€24k▼ 52.3%€20k▼ 19.1%€21k▲ 6.2%
Net result€23k-€35k▲ 47.9%€10k▼ 70.9%€13k▲ 28.8%€8k▼ 39.4%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 6% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €468k
Fixed assets
€393k ▲ 273%
Current assets
€74k ▼ 24.4%
Equity and liabilities €476k
Equity
€115k ▲ 7.3%
Debt
€361k ▲ 272%
Debt's share of the balance-sheet total rises from 47.6% to 75.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€71k▲
2023 · €29k
Cash flow
€58k▲
2023 · €22k
Current ratio
1.83▼
2023 · 2.66
Debt to equity
3.15▲
2023 · 0.91
ROE
6.8%▼
2023 · 12.1%
ROA
1.6%▼
2023 · 6.3%
Interest coverage
7.73▼
2023 · 10.11
Debt ≤ 1 year
€41k▲
2023 · €37k
Debt > 1 year
€321k▲
2023 · €60k
Income taxes
€4k▲
2023 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 46 lines
Balance sheet
Code20232024
Assets
Total assets20/58€204k€476k▲
Formation expenses20-€8k
Fixed assets21/28€105k€393k▲
Tangible fixed assets22/27€105k€392k▲
Land and buildings22€102k€382k▲
Furniture and vehicles24€4k€10k▲
Financial fixed assets28-€1k
Current assets29/58€98k€74k▼
Amounts receivable within one year40/41€47k€48k▲
Trade receivables40-€1k
Other amounts receivable41€47k€47k▲
Cash at bank and in hand54/58€42k€19k▼
Deferred charges and accrued income490/1€9k€7k▼
Equity and liabilities
Total equity and liabilities10/49€204k€476k▲
Equity10/15€107k€115k▲
Contributions10/11€19k€19k=
Reserves13€23k€31k▲
Distributable reserves133€23k€31k▲
Profit (loss) carried forward14€65k€65k▲
Amounts payable17/49€97k€361k▲
Amounts payable after more than one year17€60k€321k▲
Financial debts170/4€60k€321k▲
Amounts payable within one year42/48€37k€41k▲
Current portion of amounts payable after more than one year42€6k€20k▲
Trade debts44€8k€4k▼
Suppliers440/4€8k€4k▼
Taxes, remuneration and social security45€23k€16k▼
Taxes450/3€21k€14k▼
Remuneration and social security454/9€2k€2k▼
Income statement
Code20232024
Remuneration, social security and pensions62€3k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€50k▲
Other operating charges640/8€3k€3k▼
Gross operating margin9900€35k€74k▲
Operating profit (loss)9901€20k€21k▲
Financial income75/76B€286€352▲
Recurring financial income75€286€352▲
Financial charges65/66B€3k€9k▲
Recurring financial charges65€3k€9k▲
Profit (loss) for the period before taxes9903€17k€12k▼
Income taxes67/77€4k€4k▲
Profit (loss) for the period9904€13k€8k▼
Profit (loss) for the period to be appropriated9905€13k€8k▼
Appropriation of the result
Profit (loss) to be appropriated9906€77k€73k▼
Profit (loss) brought forward from the previous period14P€64k€65k▲
Transfer to equity691/2€13k€8k▼
To other reserves6921€13k€8k▼
The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 60 days late
2024
10-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 10 days late
2023
31-12
Financial
Equity above €100kEq €107k ▲13.8%
4 profitable years in a row build equity to €107k.
29-11
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 121 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Highest result since 2018net €35k ▲47.9%
Operating result €51k, net result €35k, both a record.
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Back to profitnet €23k
Net result €23k after one loss-making year.
17-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 48 days late
2019
31-12
Financial
Weakest financial yearnet €-21k ▼174%
Net result drops to €-21k, the lowest in the series; recovery starts the following year.
26-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Agatha-Berchem · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Koning Albertlaan 1821082 Sint-Agatha-BerchemGround area
1,184 m²
Building footprint
450 m²
Volume, LiDAR
7,331 m³
Parcel 21003A0270/00M000, Brussels · tallest building 19.6 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
KristiMed
since 20172.270.207.893
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21003A0270/00M000 | Brussels | 1,184 m² | 1 · 450 m² | 19.6 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Sarah Schacht
BE 0788.574.960
Lichtervelde · Eq €114,630
Dokter Amber Willemsen
BE 1000.724.353
Dilbeek · Eq €114,641
Dokter Roussel Deen
BE 0719.733.367
Hasselt · Eq €114,686
Centre Athéna Centrum
BE 0716.773.184
Brussel · Eq €114,493
Docteur Anthoine Médecine Générale
BE 0715.591.863
Ath · Eq €114,446
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,360 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-10-2017
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:dr.kristinator@gmail.com